RTS names Richard Carpenter mid-Atlantic sales manager

RTS Life Science, a UK-based supplier of automated sample management and drug delivery testing systems, has appointed Richard Carpenter as mid-Atlantic sales manager.

RTS names Richard Carpenter mid-Atlantic sales manager
RTS Life Science, a UK-based supplier of automated sample management and drug delivery testing systems, has appointed Richard Carpenter as mid-Atlantic sales manager. Carpenter has extensive experience in the scientific instrument market and expands the US field-based sales team.

Prior to joining RTS, Carpenter worked for LabCyte and Tecan, where he became an expert in robotics and liquid handling systems.




You may also like

Manufacturing

Software upgrade for RTS Tube Auditor

Improves screening quality, reduces costs and saves time
Manufacturing
Patented device reinvents Solid Phase Extraction

Patented device reinvents Solid Phase Extraction

Biotech Fluidics announce SPEedy - a device that provides an effortless way to perform Solid Phase Extraction (SPE) sample preparation procedures without need of an external vacuum and compatible with any adsorption chemistry or eluent composition
Regulatory
ASA bans first weight loss pill ads

ASA bans first weight loss pill ads

The UK's advertising watchdog has ruled against several companies advertising oral GLP-1 weight loss medications to the UK public, working with the MHRA to ensure compliance and "protect the public"
Regulatory
Why early notified-body engagement matters for combination product success (VIDEO)

Why early notified-body engagement matters for combination product success (VIDEO)

Learn why early notified-body engagement is critical for combination products, including design rationale, risk controls, validation evidence and traceable documentation ahead of submission.
Manufacturing
Orano Med inaugurates Europe's first industrial-scale lead-212 radioligand therapy facility

Orano Med inaugurates Europe's first industrial-scale lead-212 radioligand therapy facility

The €29m ATLab site will target up to 10,000 doses annually and its two-hour proximity to major European airports meets the critical 24-hour production-to-administration window imposed by lead-212's 10.6-hour half-life
Manufacturing
Lonza advances aseptic spray drying for high-dose biologics

Lonza advances aseptic spray drying for high-dose biologics

This new technology platform addresses stability, concentration, and delivery challenges in biologics, including new modalities
Manufacturing
Catalent launches ten-month gene-to-drug substance programme for complex biologics

Catalent launches ten-month gene-to-drug substance programme for complex biologics

The accelerated pathway extends the CDMO's Rapid Antibody framework to bispecifics and next-generation formats — targeting master cell bank release by month seven and bulk drug substance lot release by month ten
Subscribe now